Genetic alterations that inactivate KEAP1, common in lung cancer [14], lead to NRF2 activation and subsequently expression of NRF2 target genes to promote antioxidant defense, indicating that the KEAP1-NRF2 axis is closely related to ferroptosis [15,16]. The gene discussed is NFE2L2; the disease is lung cancer.